Table 1.

Ag-specific mucosal IgA Ab responses following nasal immunization with MIP-1α or MIP-1β and OVA*

Vaccine End-point titers of anti-OVA IgA Abs
FecesVaginal washNasal wash
OVA only ≤2 ≤2 ≤2  
MIP-1α plus OVA 76.8 ± 7.5 22.5 ± 3.2 9.2 ± 1.8 
MIP-1β plus OVA 153.1 ± 25.3 60.8 ± 8.1 14.8 ± 1.6 
Vaccine End-point titers of anti-OVA IgA Abs
FecesVaginal washNasal wash
OVA only ≤2 ≤2 ≤2  
MIP-1α plus OVA 76.8 ± 7.5 22.5 ± 3.2 9.2 ± 1.8 
MIP-1β plus OVA 153.1 ± 25.3 60.8 ± 8.1 14.8 ± 1.6 
*

Groups of 5 C57BL/6 mice were nasally immunized on days 0, 7, and 14 with 75 μg OVA and 0.0 or 1.0 μg MIP-1α or MIP-1β. The data presented are the mean Ab titers ± SEMs of 3 separate experiments. ELISA determined the distribution of OVA-specific serum and fecal Ab titers on day 21.

Statistically significant differences (P < .05) of Ab titers of mice that received OVA alone.

or Create an Account

Close Modal
Close Modal